Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Phase III Provenge trial resumes enrollment

Oct. 30, 2002

Interim results from phase II gastric cancer trial of pemtumomab presented

Oct. 25, 2002

Subcutaneous alemtuzumab reported to be safe and effective for B-CLL

Oct. 23, 2002

Cell Genesys reacquires full commercial rights to GVAX lung cancer vaccines

Oct. 22, 2002

Phase II Multikine trial in head and neck cancer completes enrollment

Oct. 21, 2002

EGFR-targeted MAb improves response to radiotherapy in SCCHN

Oct. 18, 2002

PrimeBoost melanoma pharmaccine advances to phase II testing

Oct. 16, 2002

Phase I trial initiated for HER-2 vaccine for breast cancer

Oct. 16, 2002

M-Vax and O-Vax INDs cleared

Oct. 15, 2002

Enrollment completed in phase II Theratope trial for metastatic colorectal cancer

Oct. 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Makary out at the FDA
BioWorld
U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with...